# Tissue Repair Gel in Venous Leg Ulcers in AU/US

> **NCT06707103** · PHASE3 · RECRUITING · sponsor: **TR Therapeutics** · enrollment: 312 (estimated)

## Conditions studied

- Venous Leg Ulcer
- Venous Ulcer
- Venous Stasis Ulcer
- Venous Stasis
- Wound Heal
- Wound
- Venous Insufficiency of Leg
- Non-healing Wound

## Interventions

- **DRUG:** TR987 0.1% gel + Standard of Care
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT06707103
- **Lead sponsor:** TR Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707103, "Tissue Repair Gel in Venous Leg Ulcers in AU/US". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06707103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*